| Literature DB >> 35282342 |
Yi Chang1, Hongyuan Lin1, Xiangyang Qian1, Hongwei Guo1, Cuntao Yu1, Xiaogang Sun1, Bo Wei1, Qiong Ma1, Yizhen Wei1, Yi Shi1.
Abstract
Background: The optimal arterial cannulation site for acute aortic dissection repair is unclear, especially for complex arch surgery. Axillary artery cannulation is widely accepted but adding femoral artery cannulation to it was considered to potentially improve perfusion and early outcomes. To clarify this point, a comparison of perioperative outcomes for these two different cannulation strategies was conducted regarding the pathological features of dissection.Entities:
Keywords: aortic dissection; cannulation; frozen elephant trunk; propensity adjustment; total arch replacement
Year: 2022 PMID: 35282342 PMCID: PMC8904879 DOI: 10.3389/fcvm.2022.809493
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
Baseline characteristics.
|
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |||
| Age, year ( | 46.8 ± 10.1 | 47.3 ± 10.2 | 46.2 ± 9.8 | 0.09 | 0 (0.0) | 46.4 ± 10.0 | 46.4 ±10.1 | 46.3 ± 9.8 | 0.92 |
| Male ( | 757 (81.5) | 424 (81.1) | 333 (82.0) | 0.71 | 0 (0.0) | 633 (81.6) | 316 (81.4) | 317 (81.7) | 0.92 |
| BMI, Kg/m2 ( | 26.4 ±4.1 | 26.6 ± 4.1 | 26.2 ± 4.0 | 0.17 | 2 (0.2) | 26.2 ± 4.0 | 26.2 ± 3.9 | 26.2 ± 4.1 | 0.91 |
| HT ( | 589 (63.4) | 327 (62.5) | 262 (64.5) | 0.53 | 0 (0.0) | 497 (64.0) | 249 (64.2) | 248 (63.9) | 0.94 |
| CAD ( | 58 (6.2) | 37 (7.1) | 21 (5.2) | 0.23 | 0 (0.0) | 43 (5.5) | 22 (5.7) | 21 (5.4) | 0.88 |
| AF ( | 8 (0.9) | 3 (0.6) | 5 (1.2) | 0.31* | 0 (0.0) | 6 (0.8) | 3 (0.8) | 3 (0.8) | 1.00 |
| DM ( | 22 (2.4) | 10 (1.9) | 12 (3.0) | 0.30 | 0 (0.0) | 21 (2.7) | 9 (2.3) | 12 (3.1) | 0.66 |
| Marfan syndrome ( | 68 (7.3) | 38 (7.3) | 30 (7.4) | 0.94 | 0 (0.0) | 59 (7.6) | 30 (7.7) | 29 (7.5) | 0.89 |
| Previous stroke ( | 35 (3.8) | 22 (4.2) | 13 (3.2) | 0.42 | 0 (0.0) | 22 (2.8) | 9 (2.3) | 13 (3.4) | 0.50 |
| CRI ( | 7 (0.8) | 3 (0.6) | 4 (1.0) | 0.71* | 0 (0.0) | 6 (0.8) | 3 (0.8) | 3 (0.8) | 1.00 |
| Scr, μmol/L ( | 99.09 ± 40.80 | 102.09 ± 46.14 | 95.24 ± 32.35 | 0.008 | 2 (0.2) | 98.80 ± 41.84 | 102.55 ± 49.27 | 95.04 ± 32.40 | 0.012 |
| Previous heart surgery ( | 0.20 | 0 (0.0) | 1.00 | ||||||
| No | 895 (96.3) | 502 (96.0) | 393 (96.8) | 757 (97.6) | 380 (97.9) | 377 (97.2) | |||
| TEVAR | 12 (1.3) | 9 (1.7) | 3 (0.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |||
| AVR | 9 (1.0) | 3 (0.6) | 6 (1.5) | 7 (0.9) | 3 (0.8) | 4 (1.0) | |||
| Others | 13 (1.4) | 9 (1.7) | 4 (1.0) | 12 (1.5) | 5 (1.3) | 7 (1.8) | |||
| EF, % ( | 60.2 ± 4.3 | 60.1 ± 4.5 | 60.4 ± 4.0 | 0.18 | 4 (0.4) | 60.4 ± 4.1 | 60.4 ± 4.2 | 60.4 ±4.0 | 0.90 |
| AR>moderate ( | 110 (11.8) | 70 (13.4) | 40 (9.9) | 0.09 | 1 (0.1) | 74 (9.5) | 34 (8.8) | 40 (10.3) | 0.46 |
| Hemodynamic instability ( | 47 (5.1) | 31 (6.0) | 16 (4.1) | 0.18 | 0 (0.0) | 29 (3.7) | 13 (3.4) | 16 (4.2) | 0.58 |
| Tamponade | 10 (1.1) | 4 (0.8) | 6 (1.5) | 0.30 | 6 (0.8) | 3 (0.7) | 4 (1.0) | 0.70 | |
| Entry tear ( | 0.009 | 0 (0.0) | 0.68 | ||||||
| aAO | 608 (65.4) | 363 (69.4) | 245 (60.3) | 483 (62.2) | 243 (62.6) | 240 (61.9) | |||
| Arch | 260 (28.0) | 126 (24.1) | 134 (33.0) | 236 (30.4) | 114 (29.4) | 122 (31.4) | |||
| DTA | 61 (6.6) | 34 (6.5) | 27 (6.7) | 57 (7.3) | 31 (8.0) | 26 (6.7) | |||
| Extent ( | 0.14* | 0 (0.0) | 0.29 | ||||||
| To arch | 60 (6.5) | 41 (7.8) | 19 (4.7) | 46 (5.9) | 29 (7.5) | 17 (4.4) | |||
| To DTA | 5 (0.5) | 3 (0.6) | 2 (0.5) | 4 (0.5) | 2 (0.5) | 2 (0.5) | |||
| To distal AA | 864 (93.0) | 479 (91.6) | 385 (94.8) | 726 (93.6) | 357 (92.0) | 369 (95.1) | |||
| IA-FL ( | 22 (2.4) | 13 (2.5) | 9 (2.2) | 0.79 | 0 (0.0) | 19 (2.4) | 10 (2.6) | 9 (2.3) | 1.00 |
| IAS ( | 23 (2.5) | 15 (2.9) | 8 (2.0) | 0.37 | 0 (0.0) | 15 (1.9) | 8 (2.1) | 7 (1.8) | 1.00 |
| Coronary malperfusion ( | 26 (2.8) | 19 (3.6) | 7 (1.7) | 0.07 | 0 (0.0) | 13 (1.7) | 6 (1.5) | 7 (1.8) | 1.00 |
| Cerebral malperfusion ( | 0.004* | 0 (0.0) | 0.80 | ||||||
| No | 882 (94.9) | 487 (93.1) | 395 (97.3) | 757 (97.6) | 380 (97.9) | 377 (97.2) | |||
| Unilateral | 45 (4.8) | 35 (6.7) | 10 (2.5) | 17 (2.2) | 7 (1.8) | 10 (2.6) | |||
| Bilateral | 2 (0.2) | 1 (0.2) | 1 (0.2) | 2 (0.3) | 1 (0.3) | 1 (0.3) | |||
| SMA-malperfusion ( | 0.85* | 0 (0.0) | 0.97 | ||||||
| No | 777 (83.6) | 434 (83.0) | 343 (84.5) | 659 (84.9) | 331 (85.3) | 328 (84.5) | |||
| Dynamic | 131 (14.1) | 78 (14.9) | 53 (13.1) | 98 (12.6) | 48 (12.4) | 50 (12.9) | |||
| Static | 19 (2.0) | 10 (1.9) | 9 (2.2) | 18 (2.3) | 9 (2.3) | 9 (2.3) | |||
| Mix | 2 (0.2) | 1 (0.2) | 1 (0.2) | 1 (0.1) | 0 (0.0) | 1 (0.3) | |||
| Renal malperfusion | 62 (6.7) | 32 (6.1) | 30 (7.4) | 0.44 | 59 (7.6) | 32 (8.2) | 27 (7.0) | 0.50 | |
| Left lower limb malperfusion ( | 0.15* | 0 (0.0) | 0.99 | ||||||
| No | 876 (94.3) | 498 (95.2) | 378 (93.1) | 730 (94.1) | 366 (94.3) | 364 (93.8) | |||
| Dynamic | 51 (5.5) | 25 (4.8) | 26 (6.4) | 46 (5.9) | 22 (5.7) | 24 (6.2) | |||
| Static | 2 (0.2) | 0 (0.0) | 2 (0.5) | 0 | 0 (0.0) | 0 (0.0) | |||
| Right lower limb malperfusion ( | 0.61 | 0 (0.0) | 0.78 | ||||||
| No | 863 (92.9) | 489 (93.5) | 374 (92.1) | 722 (93.0) | 362 (93.3) | 360 (92.8) | |||
| Dynamic | 41 (4.4) | 20 (3.8) | 21 (5.2) | 38 (4.9) | 19 (4.9) | 19 (4.9) | |||
| Static | 25 (2.7) | 14 (2.7) | 11 (2.7) | 16 (2.1) | 7 (1.8) | 9 (2.3) | |||
DAC, dual arterial cannulation; SAC, axillary artery cannulation; BMI, body mass index; HT, hypertension; CAD, coronary artery disease; AF, atrial fibrillation; DM, diabetes mellitus; CRI, chronic renal insufficiency; Scr, serum creatinine; TEVAR, thoracic endovascular aortic repair; AVR, aortic valve replacement; AR, aortic regurgitation; aAO, ascending aorta; DTA, descending thoracic aorta; AA, abdominal aorta; IA-FL, innominate artery originating from false lumen; IAS, innominate artery stenosis; and SMA, superior mesenteric artery. *Fisher's exact test was used.
Operative characteristics.
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
| Aortic root surgery ( | 0.019 | 0.07 | ||||||
| Supracoronary aortic replacement | 667 (71.8) | 377 (72.1) | 290 (71.4) | 564 (72.7) | 290 (74.7) | 274 (70.6) | ||
| Bentall | 241 (25.9) | 136 (26.0) | 105 (25.9) | 193 (24.9) | 90 (23.2) | 103 (26.5) | ||
| David | 9 (1.0) | 1 (0.2) | 8 (2.0) | 8 (1.0) | 0 (0.0) | 8 (2.1) | ||
| AVR | 12 (2.3) | 9 (1.7) | 3 (0.7) | 8 (2.1) | 3 (0.8) | |||
| CABG ( | 113 (12.2) | 66 (12.6) | 47 (11.6) | 0.63 | 83 (10.7) | 38 (9.8) | 45 (11.6) | 0.41 |
| Femoral artery bypass ( | 32 (3.4) | 22 (4.2) | 9 (2.2) | 0.35 | 30 (3.9) | 21 (5.4) | 9 (2.3) | 0.025 |
| Carotid artery bypass ( | 15 (1.6) | 10 (1.9) | 5 (1.2) | 0.42 | 13 (1.7) | 8 (2.1) | 5 (1.3) | 0.40 |
| CPB duration, min ( | 195.1 ± 68.1 | 204.8 ± 62.7 | 182.7 ± 72.7 | <0.001 | 192.6 ± 70.0 | 202.2 ± 64.6 | 183.0 ± 73.9 | <0.001 |
| X-clamp duration, min ( | 108.3 ± 33.8 | 112.9 ± 31.9 | 102.4 ± 35.3 | <0.001 | 106.6 ± 33.2 | 110.7 ± 30.3 | 102.4 ± 35.5 | <0.001 |
| HCA duration, min ( | 18.7 ± 6.8 | 18.8 ± 8.0 | 18.6 ± 4.8 | 0.51 | 18.8 ± 6.6 | 19.13 ± 8.0 | 18.5 ± 4.7 | 0.29 |
| SCP duration, min ( | 27.1 ± 8.5 | 29.5 ± 8.7 | 23.9 ± 7.0 | <0.001 | 26.8 ± 8.5 | 29.7 ± 8.9 | 23.9 ± 6.9 | <0.001 |
| Nasopharyngeal temperature, °C ( | 22.0 ± 3.6 | 21.6 ± 3.8 | 22.4 ± 3.2 | 0.001 | 21.9 ± 3.5 | 21.5 ± 3.7 | 22.4 ± 3.2 | <0.001 |
| Rectal temperature, °C ( | 24.9 ± 4.0 | 24.0 ± 3.9 | 26.2 ± 3.8 | <0.001 | 25.0 ± 4.0 | 23.9 ± 3.8 | 26.1 ± 3.9 | <0.001 |
DAC, dual arterial cannulation; SAC, axillary artery cannulation; AVR, aortic valve replacement; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; HCA, hypothermic circulatory arrest; and SCP, selective cerebral perfusion.
Perioperative outcome characteristics.
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
| MV duration, hour (median, IQR) | 22.0 (14.0–56.0) | 24.0 (14.0–64.0) | 20.0 (14.0–45.0) | 0.019* | 22.0 (14.0–50.5) | 24.0 (14.0–61.0) | 20.0 (14.0–44.5) | 0.038* |
| ICU stay, day (median, IQR) | 3.0 (2.0–6.0) | 4.0 (2.0–6.0) | 3.0 (2.0–5.0) | <0.001* | 3.0 (2.0–6.0) | 4.0 (2.0–6.0) | 3.0 (2.0–5.0) | 0.002* |
| Operative mortality ( | 57 (6.1) | 35 (6.7) | 22 (5.4) | 0.42 | 42 (5.4) | 21 (5.4) | 21 (5.4) | 1.00 |
| PMI ( | 4 (0.4) | 3 (0.6) | 1 (0.2) | 0.64† | 3 (0.4) | 2 (0.5) | 1 (0.3) | 1.00 |
| Stroke ( | 57 (6.1) | 35 (6.7) | 22 (5.4) | 0.42 | 45 (5.8) | 25 (6.4) | 20 (5.2) | 0.44 |
| Spinal cord injury ( | 49 (5.3) | 26 (5.0) | 23 (5.7) | 0.64 | 43 (5.5) | 21 (5.4) | 22 (5.7) | 1.00 |
| Reoperation for bleeding ( | 41 (4.4) | 21 (4.0) | 20 (4.9) | 0.50 | 38 (4.9) | 18 (4.6) | 20 (5.2) | 0.87 |
| IABP ( | 3 (0.3) | 1 (0.2) | 2 (0.5) | 0.58† | 3 (0.4) | 1 (0.3) | 2 (0.5) | 1.00 |
| ECMO ( | 6 (0.6) | 1 (0.2) | 5 (1.2) | 0.09† | 6 (0.8) | 1 (0.3) | 5 (1.3) | 0.22 |
| CRRT ( | 111 (11.9) | 72 (13.8) | 39 (9.6) | 0.05 | 86 (11.1) | 49 (12.6) | 37 (9.5) | 0.17 |
| Tracheotomy ( | 24 (2.6) | 15 (2.9) | 9 (2.2) | 0.53 | 21 (2.7) | 12 (3.1) | 9 (2.3) | 0.66 |
| Intestinal ischemia ( | 12 (1.3) | 8 (1.5) | 4 (1.0) | 0.46 | 9 (1.6) | 5 (1.3) | 4 (1.0) | 1.00 |
DAC, dual arterial cannulation; SAC, axillary artery cannulation; MV, mechanical ventilation; IQR, Interquartile Range; ICU, intensive care unit; PMI, perioperative myocardial infarction; IABP, intra-aortic balloon pump implantation; ECMO, extracorporeal membrane oxygenation; and CRRT, continuous renal replacement therapy. *Wilcoxon signed rank test was used..
Multivariable analyses of operative mortality, stroke, spinal cord injury, and acute renal failure requiring CRRT for dual arterial cannulation vs. single axillary artery cannulation.
|
|
|
| |
|---|---|---|---|
| Operative mortality | Axillary cannulation | ||
| Model 1 | 1.06 (0.58, 1.92) | 0.85 | |
| Model 2 | 1.04 (0.57, 1.9) | 0.89 | |
| Model 3 | 1.01 (0.55, 1.86) | 0.98 | |
| Stroke | Axillary cannulation | ||
| Model 1 | 1.11 (0.62, 1.96) | 0.73 | |
| Model 2 | 1.12 (0.63, 1.99) | 0.70 | |
| Model 3 | 1.17 (0.65, 2.11) | 0.60 | |
| Spinal cord injury | Axillary cannulation | ||
| Model 1 | 0.83 (0.45, 1.5) | 0.53 | |
| Model 2 | 0.85 (0.46, 1.54) | 0.59 | |
| Model 3 | 1.17 (0.65, 2.11) | 0.60 | |
| ARF-CRRT | Axillary cannulation | ||
| Model 1 | 1.17 (0.75, 1.81) | 0.49 | |
| Model 2 | 1.18 (0.76, 1.84) | 0.46 | |
| Model 3 | 1.24 (0.78, 1.97) | 0.36 |
OR, odds ratio; CI, confident interval. Model 1: adjusted for age/CAD/previous stroke/coronary malperfusion/cerebral malperfusion/superior mesenteric artery malperfusion/hemodynamic instability/CPB duration/preoperative serum creatinine. Model 2: adjusted for age/BMI /CAD/EF/previous stroke/chronic renal insufficiency/ aortic regurgitation>moderate/coronary malperfusion/ cerebral malperfusion/superior mesenteric artery malperfusion/hemodynamic instability/CPB duration/preoperative serum creatinine. Model 3: adjusted for age/BMI /CAD/EF/previous stroke/chronic renal insufficiency/ aortic regurgitation>moderate/coronary malperfusion/ cerebral malperfusion/superior mesenteric artery malperfusion/hemodynamic instability/CPB duration/preoperative serum creatinine/left lower limb malperfusion/right lower limb malperfusion.
Figure 1Forest plot of dual arterial cannulation vs. axillary artery cannulation regarding operative mortality by subgroups. AXA+FA, axillary artery cannulation+femoral artery cannulation; AXA, axillary artery cannulation; IA-FL, innominate artery originating from false lumen; SMA, superior mesenteric artery; and IAS, innominate artery stenosis.
Figure 4Forest plot of dual arterial cannulation vs. axillary artery cannulation regarding acute renal failure requiring dialysis by subgroups. AXA+FA, axillary artery cannulation+femoral artery cannulation; AXA, axillary artery cannulation; IA-FL, innominate artery originating from false lumen; and SMA, superior mesenteric artery.